Perimenopausal mental disorders: Epidemiology and phenomenology

CNS Spectrums

Volumn 10, Issue 6, 2005, Pages 471-478

  Rasgon, Natalie ^a   Shelton, Stephanie ^a   Halbreich, Uriel ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry and Obstetrics/Gynecology ^*

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BIPOLAR DISORDER; CLIMACTERIUM; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEADACHE; HOT FLUSH; HUMAN; INSOMNIA; MAJOR DEPRESSION; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; MENTAL INSTABILITY; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; VAGINA ATROPHY; VASOMOTOR DISORDER;

EID: 21644459288     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900023166     Document Type: Review

References (60)

1. Burt VK, Altshuler LL, Rasgon N. Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. Harv Rev Psychiatry. 1998;6(3);121-132.
2. Avis NE, McKinlay SM. The Massachusetts Women's Health Study: an epidemiologic investigation of the menopause. J Am Med Womens Assoc. 1995;50(2):45-49,63.
3. Avis NE, McKinlay SM. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas. 1991;13(1):65-79.
4. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;12:103-115.
5. Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep. 2002;4(6):419-428.
6. Novaes C, Almeida OP, de Melo NR. Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome? Climacteric. 1998;1(4):264-270.
7. Schmidt PJ, Roca CA, Bloch M, Rubinow DR. The perimenopause and affective disorders. Semin Reprod Endocrinol. 1997;15(1):91-100.
8. Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284-287.
9. Hunter MS. Somatic experiences of the menopause: a prospective study. Psychosom Med. 1990;52:357-367.
10. Collins A, Landgren BM. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas. 1994;20:101-111.
11. Jaszmann L, Van Lith ND, Zaat JCA. The perimenopausal symptoms: the statistical analysis of a survey. Med Gynaecol Social. 1969;4:268-277.
12. McKinlay SM, Jefferys M. The menopausal syndrome. Br J Prev Soc Med. 1974;28(2):108-115.
13. Ballinger CB. Psychiatric morbidity and the menopause; screening of general population sample. Br Med J. 1975;3(5979):344-346.
14. Bungay GT, Vessey MP, McPherson CK. Study of symptoms in middle life with special reference to the menopause. Br Med J. 1980;281(6234):181-183.
15. Matthews KA, Wing RR, Kuller LH, et al. Influences of natural menopause on psychological charactersitics and symptoms of middle-aged healthy women. J Consult Clin Psychol. 1990;58:345-351.
16. Adelstein AM, Downham DY, Stein Z, Susser MW. The epidemiology of mental illness in an English city. Soc Psychiatry. 1968;3:47-59.
17. Weissman MM, Myers JK. Rates and risks of depressive symptoms in a United States urban community. Acta Psychiatr Scand. 1978;57(3):219-231.
18. Hallstrom T, Samuelsson S. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand Suppl. 1985;130:13-18.
19. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas. 1992;14(2):143-135.
20. Gordon JH, Borison RL, Diamond BI. Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry. 1980;15:389-396.
21. Ball P, Knuppen R, Haupt M, Breuer H. Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. J Clin Endocrinol Metab. 1972;34(4):736-746.
22. Kumar MS, Chen CL, Muther TF. Changes in the pituitary and hypothalamic content of methionine-enkephalin during the estrous cycle of rats. Life Sci. 1979;25(19):1687-1696.
23. Guicheney P, Leger D, Barrat J, et al. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest. 1988;18(3):297-304.
24. Sherwin BB, Suranyl-Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically postmenopausal women. Biol Psychiatry. 1990;28:339-348.
25. Cone RI, Davis GA, Goy RW. Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Res Bull. 1981;7:639-644.
26. Biegon A. Effects of steroid hormones on the serotonergic system. Ann N Y Acad Sci. 1990;600:426-432.
27. Meltzer HY. Role of serotonin in depression. Ann N Y Acad Sci. 1990;600:486-499.
28. Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry. 1997;5:97-106.
29. Coiro V, Volpi R, Marchesi C, et al. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Psychoneuroendo crinology. 1993;18:551-556.
30. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Hormone therapy and affect. Maturitas. 1979:1(4):247-259.
31. Ditkoff EC, Crary WG, Cirsto M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 1991;78:991-995.
32. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind cross-over study. Psychoneuroendocrinology. 1985;10:325-335.
33. Aylward M. Estrogens, plasma tryprophan levels in perimenopausal patients. In: S Campbell, ed. The Management of the Menopause and Postmenopausal Years. Baltimore, MD: University Park Press, 1976:135-148.
34. Campbell S. Double blind psychometric studies on the effects of natural estrogens on postmenopausal women. In: S Campbell, ed. The Management of the Menopause and Postmenopausal Years. Baltimore, MD: University Park Press, 1976:149-158.
35. Montgomery JC, Appleby L, Brincat M, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987;1(8528):297-299.
36. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4(1):31-47.
37. Strickler RC, Borth R, Cecutti A, et al. The role of oestrogen replacement in the climacteric syndrome. Psychol Med. 1977;7(4):631-639.
38. Thomson J, Oswald I. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. Br Med J. 1977;2(6098):1317-1319.
39. Palinkas LA, Barrett-Bonnor E. Estrogen use and depressive symptoms in perimenopausal women. Obstet Gynecol. 1992;80:30-36.
40. Wiklund I, Holst J, Karlberg J, et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas. 1992;14:211-224.
41. Siddle NC, Fraser D, Whitehead MI, et al. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obstet Gynaecol. 1990;97:1101-1107.
42. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust. 1977;2:162-163.
43. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979;36(5):550-554.
44. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183(2):414-420.
45. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529-534.
46. Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry. 2002;63(suppl 7):45-48.
47. Shapira B, Oppenheim G, Zohar J, et al. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry. 1985;20(5):576-579.
48. Schmidt PJ, Nazli H, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 2004;161(12):2238-2244.
49. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry. 1994;164(4):513-516.
50. Porter M, Penney GC, Russell D, et al. A population based survey of women's experience of the menopause. Br J Obstet Gynaecol. 1996;103(10):1025- 1028.
51. Lindamer LA, Lohr JB, Harris MJ, Jeste DV. Gender, estrogen, and schizophrenia. Psychopharmacol Bull. 1997;33(2):221-228.
52. Andia AM, Zisook S, Heaton RK, et al. Gender differences in schizophrenia. J Nerv Ment Dis. 1995;183(8):522-528.
53. Riecher-Rossler A, Hafner H, Stumbaum M, et al. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull. 1994;20(1):203-214.
54. Riecher-Rossler A, Hafner H, Dutsch-Strobel A, et al. Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry. 1994;36(7):492-494.
55. Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry. 1993;33(3):207-209.
56. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662-673.
57. Seeman MV. Interaction of sex, age, and neuroleptic dose. Compr Psychiatry. 1983;24(2):125-128.
58. Gattaz WF, Vogel P, Riecher-Rossler A, Soddu G. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry. 1994;36(2):137-139.
59. Kulkarni J, de Castella A, Smith D. Adjunctive estrogen treatment in women with schizophrenia. Schizophr Res. 1995;15:157.
60. Lindamer LA, Buse DC, Lohr JB, Jeste DV. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry. 2001;49(1):47-51.